CHARLOTTE, N.C., July 26, 2024 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious disease and the parent company of geneType™, has conducted an operations review and announces that it intends to transition to a capital light operations model – which […]
Category Archives: Pr Newswire
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), July 26, 2024 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the positive opinion issued by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency’s […]
PARIS, July 26, 2024 /PRNewswire/ — MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and technologies that drive innovation in life science, today announced its collaboration with renowned geneticist, Professor Yannis Pitsiladis from Hong Kong Baptist University, on sports and anti-doping research. Utilizing MGI’s state-of-the-art DNBSEQ sequencers and automation platforms, the […]
HanAll reports strong financial performance with second quarter total revenue of 31.6 billion KRW, driven by the strong sales from the key products. HanAll expands collaboration with Turn Biotechnologies through an exclusive licensing agreement for Epigenetic Reprogramming of Aging (ERATM) technology, targeting ophthalmic and otic diseases. Progress in clinical development programs continued including the completion […]
BEIJING, July 26, 2024 /PRNewswire/ — On 25th July, China International Capital Corporation Limited (CICC) successfully held the 2024 CICC GBA Wealth Management Forum in Hong Kong. Themed “Developing New Quality Productive Forces, Driving New Momentum in Wealth”, the forum gathered a multitude of distinguished representatives from various sectors within the Guangdong-Hong Kong-Macao Greater Bay Area […]
SHENZHEN, China, July 26, 2024 /PRNewswire/ — Driven by production cuts and price increases from upstream manufacturers, alongside a gradual revival in the consumer electronics market, the memory industry is witnessing a recovery after two years of supply-demand imbalance and significant price declines, and behind it also hides a new trend in the industry fueled […]
JAKARTA, Indonesia, July 26, 2024 /PRNewswire/ — Bank Rakyat Indonesia (Persero) Tbk (IDX: BBRI) and its subsidiaries, BRI Group, reported a profit of IDR 29.90 trillion in the Second Quarter of 2024, achieved through selective and prudent growth. This was announced by BRI President Director, Sunarso, during the Q2 2024 financial performance press conference on […]
BOULDER, Colo., July 25, 2024 (GLOBE NEWSWIRE) — OnKure, Inc. today announced that Dylan Hartley, Ph.D. has been appointed to the position of Chief Scientific Officer. In this position, Dr. Hartley will lead the company’s research organization. “Dr. Hartley has a deep commitment to innovation and advancing drugs to improve patient care,” said Nicholas Saccomano, […]
Clinical benefit observed among non-small cell lung cancer (NSCLC) patients harboring mutant KRAS (mKRAS) variants in the Phase 2 mecbotamab vedotin (CAB-AXL-ADC) study; AXL tumoral expression highly associated with multiple mKRAS variants Evalstotug (CAB-CTLA-4 antibody) as a monotherapy and in combination with PD-1 continues to provide promising anti-tumor activity with a differentiated safety profile associated […]
SOUTH SAN FRANCISCO, Calif., July 25, 2024 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, announced today that it will report financial results for the first quarter of fiscal year 2025 (FY2025) after […]

